Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Mar 11, 2016 · 10-K · 71 days after period end · 0001213900-16-011534
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$6.54M | -$5.43M | -$5.88M | -$2.88M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 11, 2016 · 71 d after period end
